Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Investors
In the News

June 12, 2013
Bioniche Founder and CEO Addresses Shareholders

June 5, 2013
Paladin Labs Inc. and Bioniche Life Sciences Inc. Sign Debt Refinancing and Urocidin™ Licensing Deals

Investors

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Latest ASX stock price

All prices delayed at least 20 minutes.
Source: ASX Inc.


Analyst Coverage

 

Firm Analyst Contact Information
Mackie Research Capital Corp. Tania Maciver Phone: 416-860-6784

Bioniche Life Sciences Inc. is covered by the analyst listed above. Please note that any opinions, estimates or forecasts regarding the Company’s performance made by this analyst are hers alone and do not represent opinions, forecasts or predictions of Bioniche Life Sciences or its management. Bioniche Life Sciences does not, by its reference above or by distribution, imply any endorsement of or concurrence with such information, conclusions or recommendations.

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy